DeSilva Nishan M 4
4 · Cartesian Therapeutics, Inc. · Filed Nov 15, 2023
Insider Transaction Report
Form 4
DeSilva Nishan M
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−80,000→ 0 totalExercise: $4.57Exp: 2031-06-22→ Common Stock (80,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−40,000→ 0 totalExercise: $3.31Exp: 2032-01-02→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13$0.93/sh−75,000$69,750→ 0 totalExercise: $1.13Exp: 2033-01-01→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on June 23, 2021, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc.
- [F2]This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger.
- [F3]This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $69,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.